Daikyo® Crystal Zenith® 2.25mL Insert Needle Syringe System

Daikyo® Crystal Zenith® 2.25mL Insert Needle Syringe System
Product Description

The Daikyo® Crystal Zenith® (CZ) 2.25mL insert needle is a break-resistant, polymer syringe of choice to protect larger volume sensitive molecules during self-administration. For drug developers wishing to avoid glass, this syringe system protects delicate molecules as there is no silicone oil added for functionality, no lubricants, tungsten, or glue, making it a low-risk solution to the challenges of particles, interactions, and protein aggregation. Their break-resistance also reduces concern of injection malfunctions during high force, large volume injections.

APPLICATION AREAS
The hospital to home trend of moving drug administration out of the hands of clinical settings and into the hands of patients themselves has been exacerbated by the COVID-19 pandemic. A new 2.25mL auto-injector market has been created after human factor studies showed patients can tolerate >10 seconds self-injection...

Read more Show less

West Pharmaceutical Services, Inc.

  • US
  • 2017
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Packaging supplier/manufacturer
Primary activities
Contract Manufacturer
Laboratory Services
Medical Devices
Packaging & drug delivery
Regulatory Affairs
View company profile
Categories
more categories Show less

West Pharmaceutical Services, Inc.

  • US
  • 2017
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Packaging supplier/manufacturer
Primary activities
Contract Manufacturer
Laboratory Services
Medical Devices
Packaging & drug delivery
Regulatory Affairs
View company profile

More Products from West Pharmaceutical Services, Inc. (4)

  • West Ready Pack™ with NovaPure® Stoppers, Flip-Off® CCS Seals and Corning Valor® RTU VIals with SG EZ-fill® Technology

    Product West Ready Pack™ with NovaPure® Stoppers, Flip-Off® CCS Seals and Corning Valor® RTU VIals with SG EZ-fill® Technology

    Through a strategic partnership with Corning, one of the world’s leaders in glass science, West is redefining the future of containment solutions by creating a truly integrated system that will help de-risk customers’ drug development and manufacturing processes by providing comprehensive product informati...
  • Smartdose® On-Body Delivery System Platform (OBDS)

    Product Smartdose® On-Body Delivery System Platform (OBDS)

    The SmartDose platform offers a wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.
  • NovaPure® Components

    Product NovaPure® Components

    NovaPure® components have quality built in from the start. West has developed a comprehensive quality target product profile (QTPP) based on the needs of our customers and end users.
  • Daikyo Crystal Zenith® vials

    Product Daikyo Crystal Zenith® vials

    With glass-like transparency, but superior break resistance and low risk of chemical interactions, Daikyo Crystal Zenith® vials can help avoid issues including delamination, and particulates.

West Pharmaceutical Services, Inc. resources (3)

  • West Collaborates with Corning for Sustainable Drug Delivery

    News West Collaborates with Corning for Sustainable Drug Delivery

    West and Corning Launch Viridian™ Vials that provide both performance and sustainability to the healthcare industry
    26 Sep 2023
  • Design of a New Elastomer Formulation for Lyophilization Applications

    Webinar Design of a New Elastomer Formulation for Lyophilization Applications

    4040/40 elastomer formulation was designed with ‘future in mind’ to meet the ever-increasing performance & quality standards expected of primary drug packaging. The presentation will summarize the extensive Quality by Design (QbD) process that was undertaken to develop this new formulation as well as considerations taken for closure design dedicated for Lyophilization applications. Details of the extensive characterization that was performed as part of product development as well as data to demonstrates the overall performance of the new rubber formulation for lyophilization stoppers with respect to Extractables/Leachables, Particulates, Moisture, Container Closure Integrity (CCI), Particles and Manufacturability will be presented.
    2023-03-02
  • How Market Trends Drive Innovation and Enable the Pharmaceutical Pipeline

    Webinar How Market Trends Drive Innovation and Enable the Pharmaceutical Pipeline

    Our healthcare industry is evolving. The move from IV to SC injection is being driven by lifecycle management, biosimilar adoption, and the hospital to home trend. Molecules are getting more complex, and patients drive the preference for self-administration resulting in the need for more complex combination product development and quick scale up. We will present innovative solutions to these challenges to help speed up drug development and enable patient choice with: A 2.25mL polymer container system for auto-injectors which protects sensitive molecules A large volume cartridge plunger to enable primary containment within an on-body delivery system A small pack, high quality glass containment system to enable quick delivery in early-stage development
    2023-03-02